Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Reports Fourth-Quarter And Full-Year 2019 Financial Results

PR Newswire February 26, 2020

Endo Appoints Mark G. Barberio to Board of Directors

Canada NewsWire February 19, 2020

Endo Names Blaise Coleman President and Chief Executive Officer

Canada NewsWire February 19, 2020

Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate) Oral Suspension in the United States

Canada NewsWire January 27, 2020

Endo to Announce Fourth-Quarter and Full-Year 2019 Financial Results

Canada NewsWire January 24, 2020

Endo Settles Opioid Investigation with State of Oklahoma for $8.75 million

Canada NewsWire January 10, 2020

Endo to Participate at J.P. Morgan Healthcare Conference

Canada NewsWire December 17, 2019

Endo Launches Generic Version of Afinitor® (everolimus) Tablets in the United States

Canada NewsWire December 10, 2019

Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Canada NewsWire November 22, 2019

Endo Announces FDA's Acceptance of Original Biologics License Application (BLA) for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Canada NewsWire November 19, 2019

Endo Reports Third-Quarter 2019 Financial Results

Canada NewsWire November 4, 2019

Endo Implements CEO Succession Plan

Canada NewsWire November 4, 2019

Endo Aesthetics Launches New Campaign Elevating Artistry Through Scientific Innovation

Canada NewsWire October 28, 2019

Endo Presents New XIAFLEX® (collagenase clostridium histolyticum) Data at the 2019 Fall Meeting of the Sexual Medicine Society of North America (SMSNA)

Canada NewsWire October 25, 2019

Endo Presents Data on the Use of a Standing MRI for the Evaluation of Cellulite at the American Society for Dermatologic Surgery (ASDS) Annual Meeting

Canada NewsWire October 24, 2019

Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces

Canada NewsWire October 23, 2019

Nevakar Enters into $17.5 Million Product Financing Agreement with H.I.G. Capital Partners for Continued Development of Injectable Products

PR Newswire October 7, 2019

Endo to Announce Third-Quarter 2019 Financial Results

Canada NewsWire October 2, 2019

Endo Announces Successful Culmination of Litigation Regarding FDA Compounding Policy

PR Newswire September 30, 2019

Endo Announces Submission of Biologics License Application to FDA for Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Canada NewsWire September 6, 2019